Author:
Morris Karen L.,Adams Julie A.,Liu Yin John A.
Subject
Cancer Research,Oncology,Hematology
Reference9 articles.
1. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity;Finch;Cancer Research,2001
2. Pharmacokinetics, mass balance, and tissue distribution of a novel DNA alkylating agent, VNP40101M, in rat;Mao;AAPS PharmSci,2002
3. Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models;Zheng;Cancer Chemotherapy and Pharmacology,2007
4. Anti proliferative activity of ELACYT™ (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukaemia and lymphoma cells;Adams;Leukemia and Lymphoma,2008
5. A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer;Murren;Invest New Drugs,2005
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献